About us
Contact
Location
News
World News
Clinical News
UK News
Get news headlines by email
JobSearch
Search
Manage job postings
Recruiters' Directory
Get jobs by email
Advertising rates
Contacts
Magazine
Latest issue
Search past issues
Search Corporate profiles
Free subscription
Have your say
Advertising
Contact
Awards and Events
European Marketeer
UK Marketeer
RBM
Representative
Clinical Researcher
Communications Team
Recruiter
Great Oxford Debate
Joint Working Projects
US Clinical Researcher
Clubs
SOPHIE
PharmaTimes Directors' Club
Find agency
Advertising
Recruitment
Advertise
Why advertise?
Website and Archive search
Go
JobSearch
Go
Email
Password
Login
Subscribe to the archive
Forgotten password
MAGAZINE AUDIT BY
Where am I? >
Home
>
Industry News
>
World News
LATEST WORLD NEWS
FDA OKs wider use of AstraZeneca’s Crestor
Shares in AstraZeneca are on the rise this morning after US regulators gave the go-ahead for wider use of its blockbuster Crestor and allow it to be marketed as a preventative treatment for people who have normal or slightly elevated cholesterol levels
Cost-cutting and emerging markets key for Europe's drugmakers
Now that four of the six European pharma majors have reported their fourth quarter and full-year financials (Sanofi will do so on Wednesday and Bayer on February 26), cost-cutting and emerging market growth are the two striking areas, according to analysts at Collins Stewart
Alzheimer's drug Dimebon may help Huntington's patients
Medivation’s investigational Alzheimer’s disease drug Dimebon could benefit sufferers of Huntington's disease, according to a new study
Novartis buys rights to Debiopharm's hep C drug
Novartis has gained exclusive rights to develop a potential first-in-class hepatitis C treatment from fellow Swiss firm Debiopharm
Study to look at earlier use of MS drug Tysabri
As regulators once again updated the label on Tysabri over the risk of a rare brain disease, Biogen Idec and Elan Corp are planning a trial that could lead to use of the MS blockbuster at the early stages of the condition
AstraZeneca signs 'cancer metabolism' pact with charity
AstraZeneca is teaming up with Cancer Research UK in a deal that will focus on “the emerging field of cancer metabolism”
More Headlines
Teva settles US drug pricing lawsuits
Price rises "will drive US drug spend to $457.8 billion by 2019"
Putin sacks Russian drugs law critic
Japan can become a big business for GSK – Witty
GSK pipeline will give good returns on R&D spend – Witty
FDA wants more info on Protalix Gaucher drug
Roche enters into major stem cell pact
BioMarin bags PARP inhibitor with Lead Therapeutics buy
EC changes on running pharma must not be cosmetic – DTB
BREAKING NEWS: GSK coy on job loss numbers as new restructuring hits R&D
Takeda hurt by generic Prevacid but profit up
EU “pushing” India over generics in “secret” trade talks
Older >
Join PharmaTimes Directors Club
Find out more
PharmaTimes Club for Directors Secretaries
Learn more
LATEST JOBS
UK Partnership Development Manager
Account Manager
Senior Account Manager/Account Manager Flexible Remote Home Working/Office
Key Account Manager
Business Manager - Oncology
Safety Physicians – all levels
European Head of Business Development
GP/Hospital Representative
Field Trainer
Client Service Executive
Home
|
World News
|
Clinical News
|
UK News
|
Magazines
|
Competitions
|
Clubs
|
Jobs
|
Forums
|
Directory
RSS Feed
|
Advertising & Rates
|
About us
|
Contact
|
Subscribe
|
Privacy
|
Statistics
|
Design by DJM